Immunomodulatory effects of selected cyanobacterial peptidesin vitro

    loading  Checking for direct PDF access through Ovid


Cyanobacteria produce many biologically active metabolites synthesized via nonribosomal synthetic pathways such as cyclic microcystins (MCs) and linear aeruginosins (Aers). The present study aimed to investigate the effects of different MC variants and the newly isolated aerugenosin Aer-865 on macrophages, which represent one of the key effector cells within the innate immune responses. Specifically, our study included RAW 264.7 macrophage activation associated with production of cytotoxic and cytostatic nitric oxide (NO) as well as pro-inflammatory mediators like tumor necrosis factor α (TNFα) and interleukin 6 (IL-6). From the compounds investigated, commonly occurring MC variants (-RR, -YR) and Aer-865 had no significant effects within the non-cytotoxic concentrations tested, i.e. 0.001–1 μM for MCs and 0.1–50 μM for Aer-865. In contrast to known immunoactive MC-LR, the negligible immunomodulatory potential of tested MC congeners could be related to their differences in structure. The knowledge of MC structure-specific activities contributes to the understanding of complex toxicity of different MC variants and most importantly their mixtures. This study is one of the first study that evaluate the effect of larger set of cyanobacterial peptides on macrophages and compare their immunomodulatory potential.HighlightsImmunomodulatory potency significantly differ among cyanobacterial peptides.The cyclic microcystin-RR and -YR have negligible effect on macrophages.New structure-activity relationship is discussed for cyclic microcystins.Newly isolated linear cyanobacterial peptide aeruginosin-865 has no effect on macrophages.Revealed structure specific effects clarify the risks associated with the mixture of cyanobacterial toxins.

    loading  Loading Related Articles